Teva, Intel partner on machine learning tech for Huntington's Disease

Teva and Intel hope to spur the development of next-gen treatment options by better understanding the progression of the disease and how current treatments impact a patients' quality of life.

source Latest blogs for ZDNet http://ift.tt/2cAvaMl